CLOV vs. AVDX

Last updated Jun 9, 2026

CLOV (Clover Health Investments, Corp.) and AVDX (AvidXchange Holdings, Inc.) are both stocks. CLOV operates in Healthcare Plans (Healthcare), while AVDX operates in Software - Infrastructure (Technology). At a 0.33 correlation, their price movements are largely independent.

Performance

CLOV vs. AVDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and AvidXchange Holdings, Inc. (AVDX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CLOV

• 1D: 2.35%
• 1M: 25.64%
• YTD: 66.81%
• 6M: 53.13%
• 1Y: 28.31%
• 3Y*: 57.67%
• 5Y*: -25.36%
• 10Y*: —

AVDX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CLOV vs. AVDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CLOV Clover Health Investments, Corp.	66.81%	-25.40%	230.85%	2.43%	-75.01%	-53.79%
AVDX AvidXchange Holdings, Inc.	0.00%	-3.29%	-16.55%	24.65%	-34.00%	-39.62%

Correlation

The correlation between CLOV and AVDX is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (All Time) Calculated using the full available price history since Oct 14, 2021	0.33

Over the past year, the correlation between CLOV and AVDX has dropped to 0.08 - well below their long-term average of 0.33, suggesting their price drivers have been diverging.

Fundamentals

Market Cap CLOV : $2.05B AVDX : $2.07B
EPS CLOV : -$0.11 AVDX : -$0.04
PS Ratio CLOV : 0.91 AVDX : 4.63
PB Ratio CLOV : 6.03 AVDX : 3.01
Total Revenue (TTM) CLOV : $2.21B AVDX : $446.72M
Gross Profit (TTM) CLOV : $939.14M AVDX : $323.96M
EBITDA (TTM) CLOV : -$55.21M AVDX : $36.84M

Return for Risk

CLOV vs. AVDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV

CLOV Risk / Return Rank: 56
CLOV Sharpe Ratio Rank: 56
CLOV Sortino Ratio Rank: 57
CLOV Omega Ratio Rank: 57
CLOV Calmar Ratio Rank: 55
CLOV Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLOV vs. AVDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and AvidXchange Holdings, Inc. (AVDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CLOV	AVDX	Difference
Sharpe ratio: Return per unit of total volatility	0.41	—	—
Sortino ratio: Return per unit of downside risk	1.08	—	—
Omega ratio: Gain probability vs. loss probability	1.14	—	—
Calmar ratio: Return relative to maximum drawdown	0.51	—	—
Martin ratio: Return relative to average drawdown	0.93	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CLOV	AVDX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.41	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.33	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.17	—	—

Drawdowns

Drawdown Indicators

	CLOV	AVDX	Difference
Max Drawdown Largest peak-to-trough decline	-97.19%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-55.50%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-64.73%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-95.86%	—	—
Current Drawdown Current decline from peak	-82.30%	—	—
Average Drawdown Average peak-to-trough decline	-76.63%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	30.48%	—	—

Volatility

Volatility by Period

	CLOV	AVDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.92%	—	—
Volatility (6M) Calculated over the trailing 6-month period	40.34%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	69.47%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.08%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.65%	—	—

Dividends

CLOV vs. AVDX - Dividend Comparison

Neither CLOV nor AVDX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

CLOV vs. AVDX - Profitability Comparison

The chart below illustrates the profitability comparison between Clover Health Investments, Corp. and AvidXchange Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

AVDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AvidXchange Holdings, Inc. reported a gross profit of 79.62M and revenue of 110.57M. Therefore, the gross margin over that period was 72.0%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

AVDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AvidXchange Holdings, Inc. reported an operating income of -12.41M and revenue of 110.57M, resulting in an operating margin of -11.2%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.

AVDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AvidXchange Holdings, Inc. reported a net income of -9.46M and revenue of 110.57M, resulting in a net margin of -8.6%.

Frequently Asked Questions

Can I hold both CLOV and AVDX in my portfolio?

CLOV and AVDX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.